BestCo is a leading developer and manufacturer of confectionery-based Consumer Healthcare products, including OTC Drugs and Dietary Supplements. We specialize in Contract Manufacturing and Private Label product solutions for Marketers and Retailers of Consumer Healthcare products, many of whom are household names. Our roots date back to 1931 where we grew to become the largest candy company in South Africa. Beacon Sweets was established as a candy manufacturer in New Jersey in 1976 and after continued growth, expansion led us to relocate to our current site in Mooresville, North Carolina in 1988.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Business Insights

THERAPEUTICSMD AND EW HEALTHCARE PARTNERS ANNOUNCE DEFINITIVE AGREEMENT FOR EW HEALTHCARE PARTNERS TO ACQUIRE THERAPEUTICSMD

TherapeuticsMD, Inc | June 01, 2022

news image

TherapeuticsMD, Inc. an innovative, leading women’s healthcare company, announced that it has entered into a definitive merger agreement to be acquired by an affiliate of EW Healthcare Partners, a private equity firm dedicated to making investments in rapidly growing healthcare companies. Under the terms of the transaction, which has been unanimously approved by TXMD’s board of directors, EW Healthcare Partners will commence a tender offer to acquire all outstanding sh...

Read More

ORION BIOTECHNOLOGY SUCCESSFULLY ACCOMPLISHES PHASE 1 CLINICAL TRIAL OF A FIRST-IN-CLASS PRECISION ENGINEERED LIGAND ANALOG FOR HIV PREVENTION

Orion Biotechnology Canada Ltd | October 16, 2020

news image

Orion Biotechnology Canada Ltd., a clinical stage pharmaceutical company focused on precision engineering GPCR-targeted therapeutics, today announced the results of their Phase 1 study of OB-002H which is an investigational candidate microbicide for HIV prevention. The Phase 1 study was a first-in-man trial designed to evaluate the safety, acceptability, and pharmacokinetic profile of OB-002H gel. OB-002, a highly potent chemokine analog of CCL5 (a ligand for the CCR5 HIV co-receptor), has previ...

Read More

Business Insights

ELLIPSES PHARMA AND SUNROCK BIOPHARMA ENTER INTO A LICENSING AGREEMENT FOR A FIRST-IN-CLASS BIFUNCTIONAL HER3:TRAIL FUSION PROTEIN

SunRock Biopharma S.L | May 26, 2022

news image

SunRock Biopharma S.L. a biopharmaceutical company that is developing a portfolio of innovative bispecific antibodies to treat incurable cancer, and Ellipses Pharma Limited a global drug development company focused on accelerating the development of new oncology treatments, announce that they have entered into an exclusive licensing agreement for SRB22, a fully human bifunctional HER3:TRAIL fusion protein, which going forward will be known as EP0017. Under the agreement, Ellipses ...

Read More

PHARMACY MARKET

TAILORMED PARTNERS WITH EAGLE PHARMACEUTICALS TO STREAMLINE PATIENT FINANCIAL ASSISTANCE ENROLLMENT

Business Wire | October 25, 2023

news image

TailorMed, a leading technology company offering the nation’s largest network of patients, providers, pharmacies, life science companies, and other partners dedicated to improving healthcare affordability, announced Eagle Pharmaceuticals, Inc. will be implementing TailorMed’s Express Enroll solution. This partnership will introduce new efficiencies in seeking to secure financial ass...

Read More
news image

Business Insights

THERAPEUTICSMD AND EW HEALTHCARE PARTNERS ANNOUNCE DEFINITIVE AGREEMENT FOR EW HEALTHCARE PARTNERS TO ACQUIRE THERAPEUTICSMD

TherapeuticsMD, Inc | June 01, 2022

TherapeuticsMD, Inc. an innovative, leading women’s healthcare company, announced that it has entered into a definitive merger agreement to be acquired by an affiliate of EW Healthcare Partners, a private equity firm dedicated to making investments in rapidly growing healthcare companies. Under the terms of the transaction, which has been unanimously approved by TXMD’s board of directors, EW Healthcare Partners will commence a tender offer to acquire all outstanding sh...

Read More
news image

ORION BIOTECHNOLOGY SUCCESSFULLY ACCOMPLISHES PHASE 1 CLINICAL TRIAL OF A FIRST-IN-CLASS PRECISION ENGINEERED LIGAND ANALOG FOR HIV PREVENTION

Orion Biotechnology Canada Ltd | October 16, 2020

Orion Biotechnology Canada Ltd., a clinical stage pharmaceutical company focused on precision engineering GPCR-targeted therapeutics, today announced the results of their Phase 1 study of OB-002H which is an investigational candidate microbicide for HIV prevention. The Phase 1 study was a first-in-man trial designed to evaluate the safety, acceptability, and pharmacokinetic profile of OB-002H gel. OB-002, a highly potent chemokine analog of CCL5 (a ligand for the CCR5 HIV co-receptor), has previ...

Read More
news image

Business Insights

ELLIPSES PHARMA AND SUNROCK BIOPHARMA ENTER INTO A LICENSING AGREEMENT FOR A FIRST-IN-CLASS BIFUNCTIONAL HER3:TRAIL FUSION PROTEIN

SunRock Biopharma S.L | May 26, 2022

SunRock Biopharma S.L. a biopharmaceutical company that is developing a portfolio of innovative bispecific antibodies to treat incurable cancer, and Ellipses Pharma Limited a global drug development company focused on accelerating the development of new oncology treatments, announce that they have entered into an exclusive licensing agreement for SRB22, a fully human bifunctional HER3:TRAIL fusion protein, which going forward will be known as EP0017. Under the agreement, Ellipses ...

Read More
news image

PHARMACY MARKET

TAILORMED PARTNERS WITH EAGLE PHARMACEUTICALS TO STREAMLINE PATIENT FINANCIAL ASSISTANCE ENROLLMENT

Business Wire | October 25, 2023

TailorMed, a leading technology company offering the nation’s largest network of patients, providers, pharmacies, life science companies, and other partners dedicated to improving healthcare affordability, announced Eagle Pharmaceuticals, Inc. will be implementing TailorMed’s Express Enroll solution. This partnership will introduce new efficiencies in seeking to secure financial ass...

Read More

Resources

resource image

Pharma Tech

ValGenesis e-Logbook

Video

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us